Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

NovaBay Pharmaceuticals Inc (NYSE MKT LLC:NBY)

2.58
Delayed Data
As of 3:58pm ET
 +0.08 / +3.20%
Today’s Change
1.63
Today|||52-Week Range
16.94
+27.72%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues6.9M3.5M1.1M4.4M
 
 
 
 
 
Cost of Goods Sold0.00162.0K254.0K1.1M
 
 
 
 
Depreciation And Amortization341.0K314.0K232.0K164.0K
 
 
 
 
 
 
Operating ExpensesGross Income6.6M3.0M568.0K3.1M
 
 
 
 
 
General Expenses14.9M18.5M17.4M24.1M
 
 
 
 
 
Research And Development9.3M12.5M9.5M6.0M
 
 
 
 
 
Total Operating Expenses15.3M19.0M17.9M25.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-8.3M-15.5M-16.9M-21.0M
 
 
 
 
 
Extraordinary Credit1.4M--1.7M2.1M
 
 
 
 
Extraordinary Charge0.00-555.0K--0.00
 
 
Other Expenses-155.0K1.0K22.0K-96.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-7.0M-16.0M-15.2M-19.0M
 
 
 
 
 
Income Taxes-2.0K-2.0K-2.0K-12.0K
 
 
 
 
 
Net Income-7.0M-16.0M-15.2M-19.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.2M1.5M2.0M2.8M
 
 
 
 
 
Shares To Calculate EPS Diluted1.2M1.5M2.0M2.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$6.00-$10.50-$7.75-$6.82
 
 
 
 
 
EPS Diluted-$6.00-$10.50-$7.75-$6.82